AMPLIDYNE INC
NT 10-Q, 1997-05-15
ELECTRONIC COMPONENTS, NEC
Previous: OPPENHEIMER DEVELOPING MARKETS FUND, 485BPOS, 1997-05-15
Next: CORNELL CORRECTIONS INC, 10-Q, 1997-05-15




<PAGE>
                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 12B-25

                                                 COMMISSION FILE NUMBER-0-21931

                           NOTIFICATION OF LATE FILING

(CHECK ONE)

__FORM 10-K AND FORM 10-KSB__FORM 20-F__FORM 11-K X FORM 10-Q AND FORM 10-QSB
FORM__N-SAR

                  FOR PERIOD ENDED MARCH 31, 1997 
                  __ TRANSITION REPORT ON FORM 10-K AND FORM 10-KSB 
                  __ TRANSITION REPORT ON FORM 20-F 
                  __ TRANSITION REPORT ON FORM 11-K 
                  __ TRANSITION REPORT ON FORM 10-Q AND FORM 10-QSB 
                  __ TRANSITION REPORT ON FORM N-SAR 
                  FOR THE TRANSITION PERIOD ENDED:_______________

             READ INSTRUCTIONS (ON BACK PAGE) BEFORE PREPARING FORM.
                              PLEASE PRINT OR TYPE.

        NOTHING IN THIS FORM SHALL BE CONSTRUED TO IMPLY THAT THE COMMISSION HAS
VERIFIED ANY INFORMATION CONTAINED HEREIN.

        IF THE NOTIFICATION RELATES TO A PORTION OF THE FILING CHECKED ABOVE,
IDENTIFY THE ITEM(S) TO WHICH THE NOTIFICATION RELATES:

PART I--REGISTRANT INFORMATION

Full Name of Registrant: AMPLIDYNE, INC.

Former Name of Registrant:_______________________

Address of Principal Executive Office (Street and Number):
144 BELMONT DRIVE, SOMERSET, NJ 08873

PART II--RULES 12B-25(B) AND (C)

If the subject report could not be filed without unreasonable effort or expense
and the

<PAGE>



registrant seeks relief pursuant to Rule 12b-25b, the following should be
completed. 


(Check box if appropriate): 

[X] (a) The reasons described in reasonable detail in Part III of this form
        could not be eliminated without unreasonable effort or expense;

[X] (b) The subject annual report, semi-annual report, transition report on
        Forms 10- K, 10-KSB, Form 20-F, 11-K, Form N-SAR, or portion thereof,
        will be filed on or before the fifteenth calendar day following the
        prescribed due date; or the subject quarterly report or transition
        report on Forms 10-Q, 10-QSB, or portion thereof will be filed on or
        before the fifth calendar day following the prescribed due date; and

[ ] (c) The accountant's statement or other exhibit required by Rule
        12b-25(c) has been attached if applicable.

PART III--NARRATIVE

State below in reasonable detail the reasons why the Forms 10-K, 10-KSB, 20-F,
11-K, 10- Q,10-QSB, N-SAR, or the transition report or portion thereof, could
not be filed within the prescribed time period. (ATTACH EXTRA SHEETS IF NEEDED)

         The Company has not been able to compile the requisite financial data
and other narrative information neccessary to enable it to have sufficient time
to complete the Company's Quarterly Report on Form 10-QSB by May 15, 1997, the
required filing date, without unreasonable effort and expense.

PART IV--OTHER INFORMATION

(1)      Name and telephone number of person to contact in regard to this
         notification

         Devendar S. Bains         (908)                    271-8473
           (NAME)                (AREA CODE)          (TELEPHONE NUMBER)

(2)      Have all other periodic reports required under Section 13 or 15(d) of
         the Securities Exchange Act of 1934 or Section 30 of the Investment
         Company Act of 1940 during the preceding 12 months (or for such shorter
         period that the registrant was required to file such reports) been
         filed? If answer is no, identify report(s).  X Yes   ___No

(3)      Is it anticipated that any significant change in results of operations
         from the corresponding period for the last fiscal year will be
         reflected by the earnings statements to be included in the subject
         report or portion thereof?  ___Yes    X No

         If so, attach an explanation of the anticipated change, both
         narratively and quantitatively, and, if appropriate, state the reasons
         why a reasonable estimate of the results cannot be made.


<PAGE>

                                 AMPLIDYNE, INC.
                  (Name of Registrant as Specified In Charter)

has caused this notification to be signed on its behalf by the undersigned
hereto duly authorized

Dated: May 15, 1997                         AMPLIDYNE, INC.
                                          
                                            By:      /s/ Devendar S. Bains
                                                     --------------------------
                                                     Chief Executive Officer

INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly authorized representative. The name and title of the person
signing the form shall be typed or printed beneath the signature. If the
statement is signed on behalf of the registrant by an authorized representative
(other than an executive officer), evidence of the representatives's authority
to sign on behalf of the registrant shall be filed with the form.

                                    ATTENTION

INTENTION MISSTATEMENTS OR OMISSIONS OF FACT CONSTITUTE FEDERAL CRIMINAL
VIOLATIONS (SEE 18 U.S.C. 1001).

                              GENERAL INSTRUCTIONS

1.       This form is required by Rule 12b-25 (17 CFR 240.12b-25) of the General
         Rules and Regulations under the Securities Exchange Act of 1934.

2.       One signed original and four conformed copies of this form and
         amendments thereto must be completed and filed with the Securities and
         Exchange Commission, Washington, D.C. 20549, in accordance with Rule
         0-3 of the General Rules and Regulations under the Act. The information
         contained in or filed with the form will be made a matter of public
         record in the Commission files.

3.       A manually signed copy of the form and amendments thereto shall be
         filed with each national securities exchange on which any class of
         securities of the registrant is registered.

4.       Amendments to the notifications must also be filed on form 12b-25 but
         need not restate information that has been correctly furnished. The
         form shall be clearly identified as an amendment notification.



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission